Hansa Biopharma AB (HNSBF)
2.93
0.00 (0.00%)
USD |
OTCM |
Sep 20, 16:00
Hansa Biopharma Shareholders Equity (Quarterly): -20.62M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -20.62M |
| March 31, 2024 | -35.13M |
| December 31, 2023 | -16.68M |
| September 30, 2023 | -5.699M |
| June 30, 2023 | 16.78M |
| March 31, 2023 | 40.05M |
| December 31, 2022 | 57.85M |
| September 30, 2022 | 30.96M |
| June 30, 2022 | 47.17M |
| March 31, 2022 | 68.86M |
| December 31, 2021 | 83.74M |
| September 30, 2021 | 102.30M |
| June 30, 2021 | 121.07M |
| March 31, 2021 | 131.89M |
| December 31, 2020 | 151.69M |
| September 30, 2020 | 149.26M |
| June 30, 2020 | 40.55M |
| March 31, 2020 | 47.27M |
| December 31, 2019 | 60.23M |
| September 30, 2019 | 68.30M |
| June 30, 2019 | 81.51M |
| March 31, 2019 | 89.85M |
| December 31, 2018 | 95.75M |
| September 30, 2018 | 56.98M |
| June 30, 2018 | 60.12M |
| Date | Value |
|---|---|
| March 31, 2018 | 70.97M |
| December 31, 2017 | 77.12M |
| September 30, 2017 | 20.69M |
| June 30, 2017 | 23.49M |
| March 31, 2017 | 26.87M |
| December 31, 2016 | 31.29M |
| September 30, 2016 | 16.19M |
| June 30, 2016 | 18.96M |
| March 31, 2016 | 23.48M |
| December 31, 2015 | 25.15M |
| September 30, 2015 | 27.46M |
| June 30, 2015 | 29.65M |
| March 31, 2015 | 4.601M |
| December 31, 2014 | 6.424M |
| June 30, 2014 | 10.50M |
| December 31, 2013 | 7.074M |
| June 30, 2013 | 8.104M |
| June 30, 2013 | 8.104M |
| December 31, 2012 | 9.319M |
| June 30, 2012 | 9.676M |
| June 30, 2012 | 9.676M |
| December 31, 2011 | 4.689M |
| June 30, 2011 | 7.720M |
| December 31, 2010 | 4.767M |
| June 30, 2010 | 5.57M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-35.13M
Minimum
Mar 2024
151.69M
Maximum
Dec 2020
56.99M
Average
52.56M
Median
Shareholders Equity (Quarterly) Benchmarks
| Abliva AB | 6.352M |
| Karolinska Development AB | 115.99M |
| Calliditas Therapeutics AB | 10.06M |
| Oncopeptides AB | 12.22M |
| BioInvent International AB | 103.41M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 96.99M |
| Total Liabilities (Quarterly) | 117.61M |
| Debt to Equity Ratio | -4.371 |
| Current Ratio | 3.048 |
| Net Debt Paydown Yield | -1.32% |